Concepedia

J Wernz

JW

23

Publications

2.9K

Citations

20

H-Index

1984

Active since

Affiliations

New York University(Current)

Columbia University Irving Medical Center

University of Southern California

European Institute of Oncology

Southern California University for Professional Studies

J Wernz is an author at New York University specializing in medicine, oncology, and pharmacotherapy.

Top concepts

Publications per year

1984–1998

23

Publications

23

Lymphoid Neoplasia Associated with the Acquired Immunodeficiency Syndrome (AIDS)

D M Knowles, Glenn A. Chamulak, Milayna Subar et al. · Annals of Internal Medicine · 1988 · 506 citations

Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee.

Susan E. Krown, Craig E. Metroka, J Wernz · Journal of Clinical Oncology · 1989 · 474 citations

, , +17

Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma.

Parkash S. Gill, J Wernz, David T. Scadden et al. · Journal of Clinical Oncology · 1996 · 437 citations

ICRF-187 permits longer treatment with doxorubicin in women with breast cancer.

James L. Speyer, M D Green, Anne Zeleniuch‐Jacquotte et al. · Journal of Clinical Oncology · 1992 · 323 citations

Treatment of epidemic Kaposi's sarcoma with etoposide or a combination of doxorubicin, bleomycin, and vinblastine.

L Laubenstein, Robert L. Krigel, Chrystia M. Odajnyk et al. · Journal of Clinical Oncology · 1984 · 176 citations

, , +11

Rows per page

1–5 of 23